In the interests of individual patient safety and public health in general, the capacity of developing-country DRAs to regulate medicines should be strengthened. A commitment to providing reliable and affordable medicines, together with the provision of universal health services and medicines, should be embedded in national policies and strategies to improve health-care infrastructure. The capacity of DRAs to properly enforce medicines regulations must be assured...